CT引导下氩氦刀冷冻消融治疗腹部转移性肿瘤的初步报告  

CT-guided argon-helium cryoablation for abdominal metastatic tumors: a preliminary report

作　　者：黄浩哲[1,2] 许立超 李国栋[1,2] 何新红[1,2] 王英 李文涛[1,2] 

机构地区：[1]复旦大学附属肿瘤医院介入治疗科 [2]复旦大学上海医学院肿瘤学系,上海200032

出　　处：《肿瘤影像学》2014年第1期40-44,共5页Oncoradiology

基　　金：上海申康医院发展中心局级课题(No:SHDC12012112)

摘　　要：目的探讨CT引导下氩氦刀冷冻消融治疗腹部转移性肿瘤的近期临床疗效。方法选取9例确诊为腹部转移性肿瘤的患者,在CT引导下采用氩氦刀冷冻消融术治疗转移性病灶。结果 9例患者均成功手术,病灶平均冰球覆盖率为(95.0±4.8)%,平均冷冻时间(22.4±7.6)min,平均复温时间(11.2±4.6)min,患者术后1个月和3个月临床受益率分别为100.0%和91.7%;术后并发症轻微,未见冷休克、肝破裂出血及肾功能不全等严重并发症。结论 CT引导下氩氦刀冷冻消融治疗腹部转移性肿瘤安全有效,创伤微小,近期效果满意。Objective To investigate the short-term clinical benefit of cryoablation for abdominal metastatic tumors under CT guidance. Methods A total of 9 patients with confirmed abdominal metastatic tumors received argon-helium cryoablation under CT guidance. Results All patients had successful cryotherapy with the average ice-ball coverage rate of （95.0± 4.8）%. The mean cryoablation time and rewarming time was （22.4±7.6） min and （11.2±4.6） min. The clinical benefit rates of 1 and 3 months after cryoablation were 100% and 91.7%, respectively. In addition,the complications after cryoablation were mild without severe ones such as cold shock, hepatic hemorrhage and renal insufficiency. Conclusion CT-guided argon-helium cryoablation for abdominal metastatic tumors is safe,effective and minimally invasive, with satisfying clinical benefit.

关 键 词：肝转移 肾转移 冷冻消融治疗 

分 类 号：R454.5[医药卫生—治疗学]